On May 13, HLB Pharm announced that it has decided to conduct a rights offering followed by a public offering for forfeited shares in order to raise approximately 120 billion won for facility funds and other purposes.



A total of 10,762,332 new common shares will be issued at 11,150 won per share.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing